<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04076202</url>
  </required_header>
  <id_info>
    <org_study_id>BMETEU.CR.EU 13</org_study_id>
    <nct_id>NCT04076202</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Vanguard DD RP</brief_title>
  <official_title>Clinical Evaluation of Vanguard Deep Dish Rotating Platform Knee - Cementless Fixation With Finned Stem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single cohort, prospective study of performance and safety of the Vanguard Deep&#xD;
      Dish Rotating Platform (DD RP) cementless fixation with the goal to acquire clinical outcomes&#xD;
      data and evaluate the performance of the device in an Austrian patient population&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single cohort, prospective study of performance and safety of the Vanguard Deep&#xD;
      Dish Rotating Platform (DD RP) - cementless fixation with finned stem. The performance will&#xD;
      be assessed by Oxford Knee Score, and evaluation of aseptic loosening after 2 years follow&#xD;
      up. Patient benefit will be evaluated by means of Knee injury and Osteoarthritis Outcome&#xD;
      Score (KOOS) and EQ-5D patient questionnaire. The target enrollment is 113 patients in 1&#xD;
      clinical site in Linz, Austria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 11, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Actual">August 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance</measure>
    <time_frame>2 years</time_frame>
    <description>The performance will be assessed by evaluation of the rate of aseptic loosening of femoral or tibial components within 2 years follow up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient benefits</measure>
    <time_frame>10 years</time_frame>
    <description>Patient benefit will be evaluated by means of Knee injury and Osteoarthritis Outcome Score (KOOS). The KOOS evaluates both short-term and long-term consequences of knee injury.The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient benefits</measure>
    <time_frame>10 years</time_frame>
    <description>Patient benefit will be evaluated by means of European Quality of Life (EuroQol) in 5 Dimensions (EQ-5D) patient questionnaire. The questionnaire contains a descriptive system and the EQ Visual Analogue scale (VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). The EQ VAS records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. Higher EQ-5D score values indicate better outcome.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Post-traumatic Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Cementless Vanguard DD RP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving a total knee prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cementless Vanguard DD RP</intervention_name>
    <description>Patients treated with the Cementless Vanguard DD RP knee implant</description>
    <arm_group_label>Cementless Vanguard DD RP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled to undergo primary total knee replacement:&#xD;
&#xD;
               -  with painful and disabled knee joint resulting from any of the following&#xD;
                  diagnoses:&#xD;
&#xD;
               -  Osteoarthritis,&#xD;
&#xD;
               -  Traumatic arthritis,&#xD;
&#xD;
               -  Rheumatoid arthritis with one or more compartments involved.&#xD;
&#xD;
               -  Correction of varus, valgus, or posttraumatic deformity.&#xD;
&#xD;
               -  Correction or revision of unsuccessful osteotomy or arthrodesis.&#xD;
&#xD;
          -  Need to obtain pain relief and improve function.&#xD;
&#xD;
          -  Ability and willingness to follow instructions, including control of weight and&#xD;
             activity level, and to return for follow-up evaluations.&#xD;
&#xD;
          -  A good nutritional state of the patient.&#xD;
&#xD;
          -  Full skeletal maturity of the patient, patients who are at least 18 years of age.&#xD;
&#xD;
          -  Patients of either sex.&#xD;
&#xD;
          -  Consent form read, understood, and signed by patient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absolute contraindications include the following diagnoses:&#xD;
&#xD;
               -  Infection&#xD;
&#xD;
               -  Osteomyelitis&#xD;
&#xD;
               -  Previous partial or total prosthetic knee replacement on the operative side&#xD;
&#xD;
               -  Skeletal immaturity of the patient&#xD;
&#xD;
               -  Sepsis&#xD;
&#xD;
               -  Patients who are less than 18 years of age&#xD;
&#xD;
          -  Relative contraindications include:&#xD;
&#xD;
               -  uncooperative patient or patient with neurologic disorders who are incapable of&#xD;
                  following directions,&#xD;
&#xD;
               -  osteoporosis,&#xD;
&#xD;
               -  metabolic disorders which may impair bone formation,&#xD;
&#xD;
               -  osteomalacia,&#xD;
&#xD;
               -  distant foci of infections which may spread to the implant site,&#xD;
&#xD;
               -  rapid joint destruction, marked bone loss or bone resorption apparent on&#xD;
                  roentgenogram,&#xD;
&#xD;
               -  vascular insufficiency, muscular atrophy, neuromuscular disease,&#xD;
&#xD;
               -  incomplete or deficient soft tissue surrounding the knee&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabine Illi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Evidence Manager</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Gotterbarm, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kepler Universitäts Klinikum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kepler Universitäts Klinikum</name>
      <address>
        <city>Linz</city>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2019</study_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee replacement</keyword>
  <keyword>Knee Osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

